Literature DB >> 22837047

Crosstalk between JNK and NF-κB in the KDO2-mediated production of TNFα in HAPI cells.

Xuexing Zheng1, Wenwen Zheng, Shue Liu, Harshil M Patel, Xianzhu Xia, Hongsheng Ouyang, Roy C Levitt, Keith A Candiotti, Shuanglin Hao.   

Abstract

Both nuclear factor kappa B (NF-κB) and mitogen-activated protein kinases mediate production of proinflammatory cytokines in many types of cells. c-Jun N-terminal kinases (JNK) is a key regulator of many cellular events including cell inflammation and/or programmed cell death (apoptosis). In addition to mediating immune and inflammatory responses, NF-κB transcription factors control cell survival. It is reported that activation of NF-κB antagonizes apoptosis or programmed cell death by numerous triggers. It has been reported that NF-κB activation results in rapid inactivation of JNK in tumor necrosis factor alpha (TNFα)-treated murine embryonic fibroblasts. It is not clear about the relationship of JNK and NF-κB in the microglial cells induced by TLR4 activity. In the present study, we investigated the relationship of JNK and NF-κB in the highly aggressively proliferating immortalized microglial cell line treated with KDO2 (a TLR4 agonist). KDO2 treatment significantly induced the phosphorylation of JNK and NF-κB, and released TNFα. Knockdown of TLR4 with TLR4 siRNA significantly reduced phosphorylation of JNK (pJNK), phosphorylation of NF-κB, and release of TNFα. Inhibition of JNK reduced the release of TNFα, but not phosphorylation of NF-κB. Unexpectedly, inhibition of NF-κB enhanced pJNK and the release of TNFα. These results showed that TNFα induced by KDO2 was JNK-dependent, and that NF-κB negatively modulated both pJNK and TNFα in the cultured microglial cell line. The current study may provide a new insight in the modulation of TNFα in the microglial cell line.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22837047     DOI: 10.1007/s10571-012-9864-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  36 in total

1.  Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF.

Authors:  O Saito; C I Svensson; M W Buczynski; K Wegner; X-Y Hua; S Codeluppi; R H Schaloske; R A Deems; E A Dennis; T L Yaksh
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 3.  TLR signaling.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Semin Immunol       Date:  2007-02-01       Impact factor: 11.130

4.  Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain.

Authors:  Yasuhiko Kawasaki; Zhen-Zhong Xu; Xiaoying Wang; Jong Yeon Park; Zhi-Ye Zhuang; Ping-Heng Tan; Yong-Jing Gao; Kristine Roy; Gabriel Corfas; Eng H Lo; Ru-Rong Ji
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

Review 5.  Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes.

Authors:  Andy Wullaert; Karen Heyninck; Rudi Beyaert
Journal:  Biochem Pharmacol       Date:  2006-08-24       Impact factor: 5.858

6.  NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B.

Authors:  D Javelaud; F Besançon
Journal:  Oncogene       Date:  2001-07-19       Impact factor: 9.867

7.  Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation.

Authors:  Liya Qin; Guorong Li; Xun Qian; Yuxin Liu; Xuefei Wu; Bin Liu; Jau-Shyong Hong; Michelle L Block
Journal:  Glia       Date:  2005-10       Impact factor: 7.452

8.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy.

Authors:  Flobert Y Tanga; Nancy Nutile-McMenemy; Joyce A DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

Review 9.  Pathological and protective roles of glia in chronic pain.

Authors:  Erin D Milligan; Linda R Watkins
Journal:  Nat Rev Neurosci       Date:  2009-01       Impact factor: 34.870

10.  Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4.

Authors:  Christian R H Raetz; Teresa A Garrett; C Michael Reynolds; Walter A Shaw; Jeff D Moore; Dale C Smith; Anthony A Ribeiro; Robert C Murphy; Richard J Ulevitch; Colleen Fearns; Donna Reichart; Christopher K Glass; Chris Benner; Shankar Subramaniam; Richard Harkewicz; Rebecca C Bowers-Gentry; Matthew W Buczynski; Jennifer A Cooper; Raymond A Deems; Edward A Dennis
Journal:  J Lipid Res       Date:  2006-02-14       Impact factor: 5.922

View more
  3 in total

1.  Phosphorylated CCAAT/Enhancer Binding Protein β Contributes to Rat HIV-Related Neuropathic Pain: In Vitro and In Vivo Studies.

Authors:  Hyun Yi; Shue Liu; Yuta Kashiwagi; Daigo Ikegami; Wan Huang; Hirotsugu Kanda; Takafumi Iida; Ching-Hang Liu; Keiya Takahashi; David A Lubarsky; Shuanglin Hao
Journal:  J Neurosci       Date:  2017-12-01       Impact factor: 6.167

Review 2.  Kdo2 -lipid A: structural diversity and impact on immunopharmacology.

Authors:  Xiaoyuan Wang; Peter J Quinn; Aixin Yan
Journal:  Biol Rev Camb Philos Soc       Date:  2014-05-16

3.  Thyroid-Stimulating Hormone Inhibits Insulin Receptor Substrate-1 Expression and Tyrosyl Phosphorylation in 3T3-L1 Adipocytes by Increasing NF-κB DNA-Binding Activity.

Authors:  Yajing Zhang; Ling Feng
Journal:  Dis Markers       Date:  2022-03-14       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.